JP2024540097A - 核酸切断のための方法 - Google Patents

核酸切断のための方法 Download PDF

Info

Publication number
JP2024540097A
JP2024540097A JP2024525379A JP2024525379A JP2024540097A JP 2024540097 A JP2024540097 A JP 2024540097A JP 2024525379 A JP2024525379 A JP 2024525379A JP 2024525379 A JP2024525379 A JP 2024525379A JP 2024540097 A JP2024540097 A JP 2024540097A
Authority
JP
Japan
Prior art keywords
group
bifunctional molecule
molecule
nucleic acid
target nucleic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024525379A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024540097A5 (enExample
Inventor
ゴンサロ ベルナルデス
シギタス ミクティス
アンナ シブ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cambridge Enterprise Ltd
Original Assignee
Cambridge Enterprise Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Enterprise Ltd filed Critical Cambridge Enterprise Ltd
Publication of JP2024540097A publication Critical patent/JP2024540097A/ja
Publication of JP2024540097A5 publication Critical patent/JP2024540097A5/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811Selection methods for production or design of target specific oligonucleotides or binding molecules
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP2024525379A 2021-10-28 2022-10-28 核酸切断のための方法 Pending JP2024540097A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB2115540.3A GB202115540D0 (en) 2021-10-28 2021-10-28 Methods for nucleic acid cleavage
GB2115540.3 2021-10-28
PCT/EP2022/080220 WO2023073181A2 (en) 2021-10-28 2022-10-28 Methods for nucleic acid cleavage

Publications (2)

Publication Number Publication Date
JP2024540097A true JP2024540097A (ja) 2024-10-31
JP2024540097A5 JP2024540097A5 (enExample) 2025-11-05

Family

ID=78828356

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024525379A Pending JP2024540097A (ja) 2021-10-28 2022-10-28 核酸切断のための方法

Country Status (7)

Country Link
US (1) US20240417778A1 (enExample)
EP (1) EP4423295A2 (enExample)
JP (1) JP2024540097A (enExample)
AU (1) AU2022378590A1 (enExample)
CA (1) CA3236292A1 (enExample)
GB (1) GB202115540D0 (enExample)
WO (1) WO2023073181A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202300884D0 (en) * 2023-01-20 2023-03-08 Cambridge Entpr Ltd Compounds for nucleic acid cleavage
GB202300886D0 (en) * 2023-01-20 2023-03-08 Cambridge Entpr Ltd Compounds for nucleic acid cleavage

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022034177A1 (en) * 2020-08-12 2022-02-17 Cambridge Enterprise Limited Method for targeted nucleic acid cleavage

Also Published As

Publication number Publication date
WO2023073181A2 (en) 2023-05-04
GB202115540D0 (en) 2021-12-15
US20240417778A1 (en) 2024-12-19
WO2023073181A3 (en) 2023-06-08
AU2022378590A1 (en) 2024-05-09
EP4423295A2 (en) 2024-09-04
CA3236292A1 (en) 2023-05-04

Similar Documents

Publication Publication Date Title
US7109165B2 (en) Conjugates and compositions for cellular delivery
JP4358521B2 (ja) 細胞デリバリーのためのコンジュゲートおよび組成物
US20100036115A1 (en) Novel Compositions for the Delivery of Negatively Charged Molecules
JP2024540097A (ja) 核酸切断のための方法
CN108135924A (zh) 用于跨膜递送分子的化合物和方法
US20180312839A1 (en) Methods and compositions for increasing smn expression
JP2015512254A (ja) オリゴヌクレオチドアナログのボロン酸結合体
AU2018230805B2 (en) Antimicrobial compounds, compositions, and uses thereof
US20200207691A1 (en) Class of HDAC Inhibitors Expands the Renal Progenitor Cells Population and Improves the Rate of Recovery from Acute Kidney Injury
US20240277854A1 (en) Immolative cell-penetrating complexes for nucleic acid delivery to the lung
US20130079383A1 (en) Lipid Compounds Targeting VLA-4
US6855695B2 (en) Water-soluble SHPs as novel alkylating agents
KR20030063360A (ko) 에이피/에이엠피 유도 전구약물 형태
RU2651493C2 (ru) NOTCH 1-СПЕЦИФИЧЕСКИЕ МОЛЕКУЛЫ миРНК
US20170037401A1 (en) Compounds and methods for trans-membrane delivery of molecules
US11318206B2 (en) Compounds and methods for trans-membrane delivery of molecules
JP2026507782A (ja) 核酸切断のための化合物
US10266564B2 (en) Cationic lipid cordiarimide hybrid compounds and a process for preparation thereof
WO2024153952A1 (en) Compounds for nucleic acid cleavage
HK40060969A (en) Antimicrobial compounds, compositions, and uses thereof
HK1202425B (en) Integrin antagonist conjugates for targeted delivery to cells expressing lfa-1
HK1202425A1 (en) Integrin antagonist conjugates for targeted delivery to cells expressing lfa-1
Sheldon Light Controlled Drug Activation and Release

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251027

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20251027